{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_bundle","feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","contains":"body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest","slug":"vip-sciatica","urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/bundle?format=markdown"},"how_to_use":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/vip-sciatica/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/topology"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"ingest","name":"Ingest protocol","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","urls":{"write":"https://miscsubjects.com/api/protocol/ingest"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"llm_manifest","name":"LLM manifest","what":"Machine-readable read/write contract for external LLMs.","urls":{"read":"https://miscsubjects.com/api/articles/llm-manifest"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","why":"Every feature is auditable collective intelligence","how":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/vip-sciatica/bundle?format=markdown"},"imessage":null,"router":null,"related":[{"id":"topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."},{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"ingest","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."},{"id":"llm_manifest","what":"Machine-readable read/write contract for external LLMs."}],"not_medical_advice":true},"MASTHEAD":{"sorry_status":"planes not merged yet — sorry-status activates after voxel-merge-planes","identity":{"slug":"vip-sciatica","version":2,"content_hash":"6acb91632ef574b02aa3d63cfbb312f264bd1480207095ec1b4ff8271ff078b2","thread_head":"genesis","divs":30},"thesis":{"root_claim":"c1","text":"VIP expression increases after peripheral nerve injury in rat and mouse sciatic nerve models and supports remyelination and anti-inflammatory cytokine shifts in the distal stump.","tier":"preclinical"},"load_bearing":[{"id":"c5","tier":"human","status":"active","text":"In human Phase II trials, ARA-290 improved neuropathic symptoms and quality of life in patients with small fiber neuropathy from sarcoidosis or type 2 diabetes;"},{"id":"c6","tier":"human","status":"active","text":"No published human clinical trials exist for VIP, BPC-157, or TB-500 in sciatica or disc herniation."},{"id":"c2","tier":"preclinical","status":"active","text":"In a rat experimental autoimmune neuritis model, VIP treatment led to functional improvement and reduced inflammation in the sciatic nerve."},{"id":"c3","tier":"preclinical","status":"active","text":"BPC-157 improved functional recovery and rescued somatosensory neurons after sciatic nerve transection and spinal cord compression in rat models."},{"id":"c4","tier":"preclinical","status":"active","text":"Long-term thymosin beta-4 (TB-500) administration in diabetic mice prevented neuropathy progression and restored sciatic nerve motor and sensory function."}],"standing_objections":{"open":0,"strongest_open":null,"link":"https://miscsubjects.com/api/articles/vip-sciatica/discourse"},"verbs":{"read":"GET https://miscsubjects.com/api/articles/vip-sciatica/voxels — DIVs + hashes + chains (free)","read_claims":"GET https://miscsubjects.com/api/articles/vip-sciatica/claims — every formal claim as claim:<id> with current hash, thread, stable link, and exact contribution/edit bodies","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {slug, expected_thread_head, target_div?, expected_hash?, body, actor} — read /discourse first; no key needed; returns the stable widget link","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {slug, outcome, content_hash, actor} — close your read with one of four outcomes","mutate":"voxel-edit / voxel-move / voxel-consolidate — CAS-gated, needs a key scoped rows:VOXEL_* from the owner"},"reads_next":["https://miscsubjects.com/a/philosophy","https://miscsubjects.com/api/articles/vip-sciatica/discourse","https://miscsubjects.com/api/protocol"]},"bundle_version":1,"generated_at":"2026-07-29T22:26:27.384Z","slug":"vip-sciatica","title":"VIP for Sciatica: Repair Layers and the Evidence on VIP, BPC-157, TB-500, ARA-290","url":"https://miscsubjects.com/a/vip-sciatica","register":"source_ledger","tags":["peptide","matrix"],"posted_at":"2026-06-29T21:33:52.395Z","updated_at":"2026-07-17T02:43:26.961Z","body":"## What's breaking down if you have Sciatica\n\nSciatica is nerve pain along the sciatic nerve, often from disc herniation or stenosis compressing a root. The nerve signals damage or compression. Suppressing pain does not uncompress the nerve or restore tissue.\n\nBreakdown outruns repair at multiple layers: immune and autonomic signaling, structural tissue integrity, inflammation clearance and cell migration, and direct nerve fiber health. Peptides in scope are studied for specific repair pathways rather than symptom masking.\n\n## Why VIP might help you\n\n1. You have sciatica — breakdown is outpacing repair.\n2. Therefore for you: If the immune and autonomic layer is part of your problem, VIP is discussed because it targets repair pathways in nerve tissue and inflammation regulation — not because it masks pain.\n3. This article centers VIP; see other sections for BPC-157, TB-500, and ARA-290 — different layers, same condition.\n\n## Why BPC-157 might help you\n\n1. You have sciatica — breakdown is outpacing repair.\n2. What keeps failing: Poor blood supply at injury sites, weak collagen organization, slow tissue turnover.\n3. What BPC-157 is studied to do: Studied for growing new blood vessels so repair material reaches damaged tissue.\n4. Therefore for you: If the structure and tissue layer is part of your problem, BPC-157 is discussed because it targets repair — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have sciatica — breakdown is outpacing repair.\n2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin and cytoskeleton disorganization.\n3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways that help cells migrate to damage and rebuild structure.\n4. Therefore for you: If the inflammation clearance and repair-cell migration layer is part of your problem, TB-500 is discussed because it targets repair — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have sciatica — breakdown is outpacing repair.\n2. What keeps failing: Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. What ARA-290 is studied to do: Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. Therefore for you: If the nerve and innervation layer is part of your problem, ARA-290 is discussed because it targets repair — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they form a stack — not five copies of the same mechanism.\n\n- VIP targets immune and autonomic layers.\n- BPC-157 targets structure and tissue layers.\n- TB-500 targets inflammation clearance and repair-cell migration layers.\n- ARA-290 targets nerve and innervation layers.\n\nPrimary focus of this article is VIP. The others appear because the same condition breaks down on multiple layers.\n\n## What the evidence actually shows\n\nHuman data exists only for ARA-290. Preclinical animal data exists for all four. Anecdotal reports appear on forums but remain unverified.\n\n## What scientists say\n\nAnimal studies show VIP expression rises after sciatic nerve injury in rats and mice. VIP and related peptides support remyelination and reduce pro-inflammatory cytokines in the distal nerve stump after transection (source s12, s41). In a rat experimental autoimmune neuritis model, VIP treatment improved function and reduced sciatic nerve inflammation (source s17). Rat sciatic nerve studies examined VIP effects on regeneration alongside nerve growth factor (source s14).\n\nBPC-157 studies in rats show improved functional recovery and rescue of neurons after sciatic nerve transection and spinal cord compression (source s1, s6). These remain rat models.\n\nTB-500 (thymosin beta-4) in diabetic mice prevented progression of peripheral neuropathy and restored sciatic nerve function with long-term administration (source s29). Other animal work links it to cell migration in nerve repair.\n\nARA-290 has human Phase II data in small-fiber neuropathy from sarcoidosis and type 2 diabetes. It improved neuropathic symptoms, quality of life, and corneal nerve fiber density in some patients (source s33, s34). Animal work shows effects after sciatic crush injury via inflammasome pathways (source s36).\n\n## What people say on Reddit\n\nLimited direct sciatica threads appear. Some users report trying BPC-157 or TB-500 stacks for back and nerve issues with mixed personal accounts of reduced pain or improved mobility; these are unverified anecdotes without controls (source s8 equivalent reports). ARA-290 threads mention hope from human trial data on neuropathy but note cost and access issues.\n\n## What people say on X\n\nSparse mentions. Occasional posts reference animal data on nerve peptides for pain or recovery; no large verified user cohorts or before-after imaging tied to sciatica.\n\n## What we do not know\n\nNo human clinical trials exist for VIP, BPC-157, or TB-500 specifically in sciatica or disc-related nerve compression. Long-term safety, optimal combinations, and effects on actual disc height or root decompression remain unstudied in people. Weight loss effects on spinal load are established mechanically but unlinked to these peptides here.\n\n## Safety and limits\n\nAll discussed compounds lack regulatory approval for sciatica. Human data is narrow (mainly ARA-290). Animal findings do not prove human outcomes. Consult qualified medical professionals for any condition. Individual responses vary. Evidence grades are assigned per claim below.","claims":[{"id":"c6","text":"No published human clinical trials exist for VIP, BPC-157, or TB-500 in sciatica or disc herniation.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":[],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c1","text":"VIP expression increases after peripheral nerve injury in rat and mouse sciatic nerve models and supports remyelination and anti-inflammatory cytokine shifts in the distal stump.","tier":"preclinical","weight":0.5,"effective_weight":0.5,"slot":null,"source_ids":["s12"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c5","text":"In human Phase II trials, ARA-290 improved neuropathic symptoms and quality of life in patients with small fiber neuropathy from sarcoidosis or type 2 diabetes; some showed corneal nerve fiber regrowth.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s33","s34"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c2","text":"In a rat experimental autoimmune neuritis model, VIP treatment led to functional improvement and reduced inflammation in the sciatic nerve.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s17"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c3","text":"BPC-157 improved functional recovery and rescued somatosensory neurons after sciatic nerve transection and spinal cord compression in rat models.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s1","s6"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c4","text":"Long-term thymosin beta-4 (TB-500) administration in diabetic mice prevented neuropathy progression and restored sciatic nerve motor and sensory function.","tier":"preclinical","weight":0.5,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s29"],"who_claims":"grok/grok-4.3","status":"active"}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6604284/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","summary":"Rat studies on BPC-157 after nerve and spinal injury showing recovery metrics.","quote":"In animals, BPC 157 has an anti-inflammatory effect and therapeutic effects in functional recovery and the rescue of somatosensory neurons in the sciatic nerve after transection.","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"defbe6352634dc39"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","summary":"Detailed rat spinal cord compression model with BPC-157 outcomes.","quote":"BPC 157 application largely counteracted changes at the microscopic level... in the rat caudal nerve.","quote_status":"unverified","link_status":"ok","claim_ids":["c3"],"hash":"181d98b7dea8442c"},{"id":"s12","type":"pubmed","url":"https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2019.01326/full","title":"Distinct VIP and PACAP Functions in the Distal Nerve Stump Following Peripheral Nerve Injury","summary":"Mouse sciatic nerve transection study showing VIP receptor upregulation in Schwann cells and macrophages; VIP effects on cytokine balance and remyelination in explants.","quote":"Our results provide evidence that VIP and PACAP could have important functions in the distal nerve stump following injury to promote remyelination and regulate the inflammatory response.","quote_status":"verified","link_status":"ok","claim_ids":["c1"],"hash":"54b0859957caf0f6"},{"id":"s17","type":"pubmed","url":"https://www.dovepress.com/the-effects-of-vasoactive-intestinal-peptide-in-the-rat-model-of-exper-peer-reviewed-fulltext-article-DDDT","title":"The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis","summary":"Rat EAN model demonstrating VIP's impact on sciatic nerve inflammation and function.","quote":"The study showed that in a rat model of EAN, treatment with VIP resulted in functional improvement, reduced inflammation of the sciatic nerve.","quote_status":"unverified","link_status":"ok","claim_ids":["c2"],"hash":"4b936bda57007022"},{"id":"s29","type":"news","url":"https://www.regenerx.com/2015-05-08-Researchers-Report-that-Long-Term-Administration-of-Thymosin-B4-in-a-Diabetic-Animal-Model-Prevents-Progression-of-Peripheral-Neuropathy-and-Restores-Sciatic-Nerve-Function","title":"Researchers Report that Long-Term Administration of Thymosin B4 in a Diabetic Animal Model Prevents Progression of Peripheral Neuropathy and Restores Sciatic Nerve Function","summary":"Press release on mouse diabetic neuropathy model with TB4 functional recovery data.","quote":"diabetic mice treated long-term with Thymosin B4 (TB4) have significantly improved motor and sensory function in the sciatic nerve compared to the untreated animals.","quote_status":"unverified","link_status":"ok","claim_ids":["c4"],"hash":"59480a62c9444bbd"},{"id":"s33","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","summary":"Review summarizing human ARA290 trials in neuropathy populations.","quote":"In humans, ARA290 has been evaluated in patients with small fiber neuropathy associated with sarcoidosis or type 2 diabetes mellitus... ARA290 significantly improved neuropathic and autonomic symptoms... initiated a regrowth of small nerve fibers in the cornea.","quote_status":"unverified","link_status":"ok","claim_ids":["c5"],"hash":"8997009dcc61d582"},{"id":"s34","type":"pubmed","url":"https://journals.lww.com/painrpts/fulltext/2016/08000/targeting_the_innate_repair_receptor_to_treat.2.aspx","title":"Targeting the innate repair receptor to treat neuropathy","summary":"Human clinical outcomes for ARA290 in sarcoidosis and diabetic neuropathy.","quote":"In patients with sarcoidosis, ARA290 significantly improved neuropathic and autonomic symptoms, as well as quality of life... In patients with T2D, the results were similar...","quote_status":"unverified","link_status":"http_403","claim_ids":["c5"],"hash":"31cd5b3c99d6ff4e"}],"voxels":{"slug":"vip-sciatica","counts":{"divs":30,"voxels":6,"sources":7,"edges":13},"note":"slim bundle — full voxels at /api/articles/vip-sciatica/voxels"},"constitution":{"url":"https://miscsubjects.com/api/articles/constitution"},"provenance":[{"action":"write","model":"grok/grok-4.3","ts":"2026-06-29T22:20:44.245Z","hash":"54674d7f9f294527","tokens_in":22353,"tokens_out":3835},{"action":"voxel_divide","model":"owner","ts":"2026-07-17T02:43:26.961Z","hash":"1fe374fdf9250392","tokens_in":0,"tokens_out":0}],"contributions":[{"id":"k1","ts":"2026-06-29T22:20:44.245Z","model":"grok/grok-4.3","role":"writer","action":"redraft","rationale":"","hash":"e4bf2ae94a019afe50fa5efe5ab2083097006827cf312d2863db306c541efa7c"}],"topology":null,"slim":true,"ledger_totals":{"claims":6,"sources":7,"exported_claims":6,"exported_sources":7},"question_graph":{"slug":"vip-sciatica","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"verification":{"provenance":{"valid":true,"entries":2,"head":"1fe374fdf92503927df3b2f71cd75f37309f1a5bdc3197ecc4e63c67ee746f10"},"sources":{"valid":true,"entries":7,"head":"31cd5b3c99d6ff4ede84fd1f3c8d20334dbaab38c2c446f71cd774d2d9657cc3"}},"counts":{"claims":6,"sources":7,"provenance":2,"contributions":1,"questions":0,"evidence_ingests":0,"voxel_edges":13},"transport":"Open every URL in this bundle with your browser or web / URL-fetch tool. Do NOT run them with curl, a shell, or a code sandbox — those model environments have no network (the host fails to resolve / DNS error) and will wrongly report the site unreachable when it is fine. Opening the link IS the call.","llm_manifest":{"version":"1","site":"https://miscsubjects.com","purpose":"Peptide evidence articles with hash-chained source ledgers, tiered claims, and a question graph. LLMs should READ bundles/URLs and WRITE back via ingest — never invent doses.","read":{"human_page":"https://miscsubjects.com/a/vip-sciatica","bundle_json":"https://miscsubjects.com/api/articles/vip-sciatica/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/vip-sciatica/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/vip-sciatica/topology","question_graph":"https://miscsubjects.com/api/articles/vip-sciatica/question-graph","sources":"https://miscsubjects.com/api/articles/vip-sciatica/sources","provenance":"https://miscsubjects.com/api/articles/vip-sciatica/provenance","contributions":"https://miscsubjects.com/api/articles/vip-sciatica/contributions","graph_topology":"https://miscsubjects.com/api/articles/vip-sciatica/graph-topology?question={question}","voxels":"https://miscsubjects.com/api/articles/vip-sciatica/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","health":"https://miscsubjects.com/api/articles/vip-sciatica/health","repair":"POST https://miscsubjects.com/api/protocol/repair","list_articles":"https://miscsubjects.com/api/articles","graph_canvas":"https://miscsubjects.com/graph.html?slugs=vip-sciatica","graph_yield":"https://miscsubjects.com/api/graph?slugs=vip-sciatica&layer=yield","obsidian_vault":"https://miscsubjects.com/api/articles/obsidian-vault?slugs=vip-sciatica","graph_query":"https://miscsubjects.com/api/v1/query?from=vip-sciatica&kind=claim&where=tier=human"},"ask":{"description":"Answer only from topology; creates a question_node with gaps.","api":"POST https://miscsubjects.com/api/protocol/ask","body":{"slug":"{slug}","question":"string"},"imessage":"vip-sciatica|your question","router_tag":"[ARTICLE_ASK]vip-sciatica|question[/ARTICLE_ASK]","auth":"x-terminal-key header for API; iMessage/WhatsApp via miscsubjects build"},"ingest":{"description":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","api":"POST https://miscsubjects.com/api/protocol/ingest","body":{"slug":"{slug}","evidence":"paste text","question_node_id":"optional qn_..."},"imessage":"ingest vip-sciatica|q:{node_id}|paste evidence","router_tag":"[ARTICLE_INGEST]vip-sciatica|evidence[/ARTICLE_INGEST]","tiers":["human","preclinical","anecdotal","mechanistic","speculative"]},"claim":{"description":"Prompt-injection style POST — one claim voxel with who_claims + posted_by provenance.","api":"POST https://miscsubjects.com/api/protocol/claim","body":{"slug":"{slug}","text":"one assertion","tier":"human|preclinical|anecdotal|mechanistic|speculative","who_claims":"study author, platform, or model id","source_ids":"optional [s1]"},"imessage":"claim vip-sciatica|tier|assertion — who claims it?","router_tag":"[ARTICLE_CLAIM]vip-sciatica|tier|assertion[/ARTICLE_CLAIM]","slots":["what_it_is","who_claims_what","what_is_known","what_is_unknown","mechanism","limitations","disclaimer"]},"tiers":{"human":0.8,"preclinical":0.5,"anecdotal":0.3,"mechanistic":0.3,"speculative":0.1},"invariants":["Self-explaining — every API JSON has _self; every paste widget has §SELF; root index at /api/articles/system-map","Append-only — revisions preserved at ?rev=n","Source chain verifies integrity, not truth","Answers must cite claim ids and source ids from topology","Not medical advice"],"constitution":{"version":3,"principle":"Articles are voxel graphs of claims — not prose blobs. Every assertion is a claim atom with tier, weight, source_ids, and posted_by provenance.","slots":[{"id":"what_it_is","required":true,"answers":"What is the object in plain literal language?"},{"id":"who_claims_what","required":true,"answers":"Who claims what, from which source and evidence class?"},{"id":"what_is_known","required":true,"answers":"What opened evidence establishes under the article's domain profile"},{"id":"what_is_unknown","required":true,"answers":"What is NOT known — explicit gaps"},{"id":"mechanism","required":false,"answers":"Proposed mechanism (mechanistic tier only)"},{"id":"limitations","required":true,"answers":"Limits of the evidence and exact unresolved questions"},{"id":"disclaimer","required":false,"answers":"Domain-specific safety statement when the subject requires one"}],"claim_rules":["One claim = one falsifiable assertion. No compound claims.","Every claim must declare tier: human|preclinical|anecdotal|mechanistic|speculative|system.","system tier = architecture/design axioms (not biological mechanism). Use for protocol self-definition.","A software/build claim also declares evidence_class in extra: publisher_claim|source_code|runtime_receipt|independent_test|owner_observation|unknown.","Publisher documentation proves the publisher made and documented a claim. It is not independent runtime proof.","Source code proves an implementation exists. A successful receipt proves one invocation. Neither proves general reliability or field superiority.","Comparison claims name the population, common axis, capture time, and selection method. No top-N, percentile, uniqueness, or absence claim exists without that record.","Sourced claims must cite source_ids from the hash-chained ledger.","Unsourced claims must set source_status: unsourced and why_material.","posted_by is mandatory on every new claim (model id, human, or channel).","No medical advice, no doses, no 'you should take'.","Bad information is retracted (status:retracted), never deleted — retraction event stays on ledger.","Adversary challenges link via challenges[] / challenged_by[] — target may be downweighted.","Leaked secrets are scrubbed to [REDACTED:secret-leak] with scrub_events tombstone — honest audit trail."],"source_rules":["Every source is a voxel edge: type, url, exact quote, summary, found_by, accessed_at.","Sources hash-chain — prev/hash on append.","Anecdotal sources must name platform (reddit|x|youtube|imessage|user_entry).","Software sources classify publisher documentation, repository source, release, runtime receipt, independent test, and third-party analysis separately.","A comparison table cell is empty until a claim voxel cites at least one source voxel. Model prose alone is not evidence."],"writing_rules":["Literal nouns and verbs. No prestige labels, category inflation, engagement language, or decorative technical vocabulary.","Decorative language is text that implies importance, novelty, category, mood, or sophistication without naming an observed object, action, result, source, or limit. Delete it.","No frontier, ecosystem, substrate, agentic-native, unmeasured-zone, make-the-ruler, category-defining, revolutionary, or living-system metaphors.","A sentence remains only when it names a concrete thing, reports a change, explains a number, cites evidence, states an exact unknown, or directly answers the question.","Technical nouns are allowed only when literal. Define the first use by what the named code or data object stores or does.","State the observed object before naming a category for it.","Keep the evidentiary boundary beside the exact claim it limits.","Unknown means unknown. Missing evidence does not become absence."],"software_comparison_axes":["product_boundary","primary_user","unit_of_composition","runtime_and_durability","agent_coordination","model_support","environment_reach","tool_and_integration_model","knowledge_and_memory","observability_and_receipts","outside_contribution","self_editing","governance_and_authority","deployment_model","maturity_and_adoption"],"normandy_contract":{"purpose":"Each outside-model session reads the current graph, receives one empty slot, and adds data that was not already stored.","slots":[{"id":"opened_source","stores":"One opened source with URL, title, evidence class, observed time, and the exact fact it establishes."},{"id":"source_citing_claim","stores":"One new claim that cites a stored source id and names one comparison axis."},{"id":"overlap","stores":"One evidenced capability both systems have."},{"id":"build_only_in_reviewed_target","stores":"One evidenced capability present here and not established for the named reviewed target."},{"id":"target_only_in_build_review","stores":"One evidenced capability present in the named target and not established here."},{"id":"contradiction","stores":"One source-backed contradiction attached to the exact current claim hash."},{"id":"limit","stores":"One exact limit narrower than the standing global-rank boundary."},{"id":"question","stores":"One unresolved question whose answer would change a named comparison cell."},{"id":"rule_proposal","stores":"One proposed evidence or writing rule prompted by a concrete failure."},{"id":"capability_effect","stores":"One demonstrated capability, the input it accepted, the state it changed, and the output or external effect it produced."},{"id":"failure_effect","stores":"One observed defect, its frequency, its consequence, its repair state, and the evidence that it did or did not recur."},{"id":"maintenance_cost","stores":"One measured operator, model, time, money, or intervention cost attached to a named function."},{"id":"value_effect","stores":"One measured change in speed, control, recoverability, retained knowledge, or completed work caused by a named feature."}],"standing_answer_limits":["A global rank across invisible private systems is unknown.","Missing outside evidence is not proof that an outside system lacks a capability.","A successful receipt proves one run, not general reliability.","Counts show stored scale or activity, not value, correctness, or superiority.","Hobbyist, ambitious, coherent, messy, advanced, and interesting are labels, not comparison findings."],"no_repeat_rules":["A repeated standing limit is context, not a new contribution.","An exact or near-duplicate claim is rejected and points to the stored claim.","A duplicate source does not complete an assignment.","A response completes only after at least one new graph object lands.","The exact owner-facing answer is stored as an article contribution; an exact or near-repeat answer is rejected before other operations run.","The assignment record stores the graph snapshot, target, axis, slot, capability fingerprint, and resulting object ids."],"assignment":"GET /api/normandy?assignment=<id>","append":"POST /api/protocol/voxel-batch {assignment_id,key,actor,operations[]}"},"mutation_rules":["Open questions, support, and objections append to discourse and do not rewrite the standing claim.","Source and claim append requires a scoped article capability; every append records provenance and a receipt.","Existing text edits use the current voxel hash. A stale hash writes nothing.","Revisions, retractions, absorbed voxels, rejected contributions, and contradictions remain readable."],"ontology_rules":["Peptide articles (bpc-157, tb-500) are tree roots.","Condition articles (bpc-157-glp1-gut-damage) branch from peptides.","Stack articles (wolverine-stack-glp1) compose peptides — never duplicate peptide mechanism prose.","If an article has no parent embeds and is not a root peptide → sprawl candidate.","Misstep = duplicate scope with another slug; merge or reparent via embeds."],"post_protocol":{"claim":"POST /api/protocol/claim","source":"POST /api/protocol/sources","ingest":"POST /api/protocol/ingest","webhook":"POST /api/articles/<slug>/webhook {kind:claim|source}","imessage_claim":"claim {slug}|{tier}|your assertion — who claims it, source?","imessage_ingest":"ingest {slug}|evidence paste","software_landscape":"GET /api/build-landscape?next=1&lane=field|build|opposition|synthesis","queue_population":"POST /api/build-landscape {action:queue_targets, cohort, query, sort, captured_at, source_url, targets[]}"}},"this_article":{"slug":"vip-sciatica","url":"https://miscsubjects.com/a/vip-sciatica","bundle_url":"https://miscsubjects.com/api/articles/vip-sciatica/bundle?format=markdown"},"voxel_procedure":{"what":"Every article has a human side (/a/vip-sciatica) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"vip-sciatica\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"vip-sciatica\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"vip-sciatica\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"vip-sciatica\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"vip-sciatica\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"vip-sciatica\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/vip-sciatica/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/vip-sciatica/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/vip-sciatica#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."}},"api_urls":{"bundle":"https://miscsubjects.com/api/articles/vip-sciatica/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/vip-sciatica/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/vip-sciatica/topology","voxels":"https://miscsubjects.com/api/articles/vip-sciatica/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","question_graph":"https://miscsubjects.com/api/articles/vip-sciatica/question-graph","ask":"https://miscsubjects.com/api/protocol/ask","ingest":"https://miscsubjects.com/api/protocol/ingest","claim":"https://miscsubjects.com/api/protocol/claim","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown"}}